Surgical Gowns, PreSource Procedural Packs Possibly Contaminated, FDA Warns
The announcement could lead to interruptions in planned surgeries, according to the FDA. The gowns also provide barrier protection.
Some Level 3 surgical gowns manufactured by Cardinal Health and the PreSource procedural packs that contain those gowns may be contaminated, Cardinal Health and the US Food and Drug Administration (FDA) warned Thursday, noting that use of the medical gear should be discontinued immediately. Both the company and the agency are working to determine the scope of the possible contamination, and Cardinal Health is expected to issue a recall soon.
The announcement could lead to interruptions in planned surgeries, according to a statement by Jeffrey E. Shuren MD, JD, director of the FDA’s Center for Devices and Radiological Health (CDRH). The gowns also provide barrier protection.
Shuren said that “there are very real consequences that medical device supply chain disruptions can have on patients, and we’re committed to taking the steps we can to mitigate any adverse patient impact.”
According to the statement, Cardinal Health is cooperating in every way with the FDA and neither the agency nor the manufacturer have identified any patients who have been affected. Cardinal Health sent an alert to customers about the problems on January 11 and then again on January 15.
In addition, Cardinal Health customers who have questions can contact the company here. “We understand the company is continuing to communicate directly with its customers about which specific products are directly impacted by the quality concern and will be issuing a recall soon,” Shuren said.
Gowns are classified into 4 levels and “Level 3 gowns provide moderate risk protection and are used in a wide-range of surgical procedures, such as open-heart surgery and knee replacements,” Shuren said. “They are intended to be worn to protect both the patient and health care personnel from transfer of microorganisms, body fluids, and particulate material.”
Cardinal Health is currently trying to pinpoint exactly which batches of products are affected.
The FDA is providing information about alternative FDA-approved Level 3 gowns on the market, and also encourages reports on shortages be submitted through this website.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
